Location of recurrent cardiovascular events and anticardiolipin antibodies-Reference-Cited by-同舟云学术

Location of recurrent cardiovascular events and anticardiolipin antibodies

Published:2021-03-11 Issue:7 Volume:51 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur. J. Clin. Invest.

Author:

Galán‐González Javier¹,Rico‐Martín Sergio²^ORCID,Calderón‐García Julián F.²,Antón Joaquín¹,Ramírez‐Moreno José M.³^ORCID,Álvarez‐Rodríguez Lorenzo R.⁴,Sánchez Muñoz‐Torrero Juan F.¹,E Aguilar,JN Alcalá‐Pedrajas,LR Alvarez,G Arnedo,R Coll,A García‐Díaz,L López‐Jiménez,M Monreal,MT Pascual,JC Sahuquillo,JF Muñoz‐Torrero,C Sanclemente,JM Suriñach,J Toril,M Yeste,

Affiliation:

1. Department of Internal Medicine Hospital San Pedro Alcántara Cáceres Spain

2. Department of Nursing, Nursing and Occupational Therapy College University of Extremadura Cáceres Spain

3. Department of Neurology Hospital Universitario de Badajoz Badajoz Spain

4. Department of Vascular Surgery CST‐Hospital de Terrassa Terrassa Spain

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13533

Reference29 articles.

1. Diagnosis and Management of the Antiphospholipid Syndrome

2. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines;Arnett DK;Circulation,2019

3. Anticardiolipin Antibodies and Recurrent Coronary Events

4. Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form

5. Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients With Ischemic Stroke

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The interaction of persistent antiphospholipid antibodies positivity and cigarette smoking is associated with an increased risk of cardiovascular events: Cross-sectional and longitudinal analysis;International Journal of Cardiology;2023-03

2. Optimal Control of all Modifiable Vascular Risk Factors Among Patients With Atherosclerotic Disease. A Real-Life Study;Current Problems in Cardiology;2023-03

3. Sustained low‐density lipoprotein‐cholesterol <70 mg/dl is associated with improved cardiovascular outcomes in the clinical setting;European Journal of Clinical Investigation;2021-12-21

4. Location of recurrent cardiovascular events and anticardiolipin antibodies;European Journal of Clinical Investigation;2021-03-11